<p>Pfizer Oncology is focused on extending its leadership in genitourinary cancers, and we are committed to developing and delivering a broad portfolio of medicines in prostate cancer that define standards of care for patients across the treatment continuum. As we build a leading global presence in prostate, we will establish two priority prostate assets: TALZENNA and Mevrometostat. With the development and launch of TALZENNA (Talazoparib), we aspire to lead biomarker driven prostate cancer in the highly competitive poly (ADP-ribose) polymerase (PARP) inhibitor landscape. With Mevrometostat we will expand on the leadership and presence by establishing a first-in-class EZH2i in both metastatic castration-resistant prostate cancer (MCRPC) and metastatic castration-sensitive prostate cancer MCSPC in all-comer populations.</p> <p>As a priority brand for the Oncology portfolio, TALZENNA in prostate cancer has the potential to deliver close to $2B in global peak revenues. We are laser focused on driving robust launch uptake of the first indication in 1L mCPRC (TALAPRO-2); approved in the U.S. in June 2023 in HRRm mCRPC, the EU in January 2024 in all-comers mCRPC, and Japan in January 2024 in BRCAm mCRPC. The Talazoparib prostate development program includes a Phase 3 study in the earlier setting of advanced prostate cancer, in combination with XTANDI for adult patients in HRRm mCSPC (TALAPRO-3). Estimated US/EU approval in 2H 2026.</p> <p>Pfizer will build on leadership in prostate cancer by launching Mevrometostat, a first in class EZH2 inhibitor that has the potential to deliver over $3B in global peak revenues. The first launch in MCRPC (MEVPRO-1) is expected in the in U.S. in 2027, with an indication expansion (MEVPRO-2) within 6-9 months after. The development program for Mevrometostat also includes Phase 3 study (MEVPRO-3) in MCSPC, in combination with XTANDI in an all-comers population. Estimated US/EU approval in 2029/2030.</p> <p>ROLE SUMMARY</p> <p>This role will be responsible for leading a team of global marketing colleagues to drive TALZENNA in-line mCRPC global brand strategy and deliver the global launches of TALZENNA in HRRm mCSPC and Mevrometostat in both MCRPC and MCPSC. This individual will partner closely with Global Medical Affairs, Global Access and Value, Global Value & Evidence, Global Product Development, PGS, US Marketing, International Commercial Office, Chief Marketing Office, Insight Strategy & Execution, and all other Enabling Functions.</p> <p>RESPONSIBILITIES</p> <ul> <li>Lead all global elements of in-line marketing, commercial development, and launch planning for two key priority brands in Prostate Cancer for Pfizer Oncology. </li><li>Chair the Talzenna Global Governance Team and lead the co-creation of the TALZENNA global brand plan in mCRPC and core content package (e.g., core creative campaign, messaging, HCP/Patient resources) </li><li>Responsible for delivering the global launch plan and key launch stage gates for TALAPRO-3 (HRRm mCSPC), including market development activities, biomarker testing strategy, and global launch readiness activities. </li><li>Responsible for delivering the global launch plan and key launch stage gates for Mevrometostat in MCRPC and MCSPC, including market development activities and global launch readiness activities. </li><li>Collaborate closely with U.S. Marketing Team, the International Commercial office and CoLab to ensure successful implementation of in-line brand strategies and launch preparations in markets. </li><li>Represent the Commercial voice on the Talzenna and Mevrometostat Global Product Teams (GPT) </li><li>Drive performance in areas of functional responsibility, optimizing Pfizer asset performance, balancing long and short-term imperatives, and contribute to overall business growth and results across relevant therapeutic areas of Pfizer. </li><li>It requires the ability to organize complex processes and tasks into manageable projects and establish oneself as a reliable and trusted partner for all relevant Pfizer colleagues worldwide that are working on prostate cancers. </li><li>Ensure Pfizer's needs are met throughout each brand's lifecycle and oversee overall therapeutic area investment and consequent returns. </li><li>Finally, the position requires the individual to build knowledge and competency across all stages of prostate cancer, understanding alternative treatment paradigms and patient management. By working in close alignment with other global commercial teams and their respective inline indications, this leader will drive incremental business opportunities for Pfizer. </li><li>Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create businessimpact. </li></ul> <p>BASIC QUALIFICATIONS</p> <p>Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact.</p> <ul> <li>Bachelor's degree with a MBA preferred </li><li>12+ years of pharma experience or relevant industry experience </li><li>Significant successful (7+ years) commercial experience </li><li>Demonstrated entrepreneurship mind-set, accountability, agility, overcoming obstacles and focus on action and implementation in line with Pfizer Culture </li><li>Demonstrated ability to set priorities, make intelligent trade-offs, and promote collaboration to deliver winning results. </li><li>Demonstrated ability to influence internal and external stakeholders and ability to work effectively at all organizational levels </li><li>Experience and demonstrated success in driving organizational change initiatives required. </li><li>Demonstrated ability to effectively lead across business in a matrix organization with a One Pfizer mind set </li><li>Demonstrated ability to create product/commercial solutions </li><li>Demonstrated ability to think and act strategically and innovatively with strong analytical skills. </li><li>Demonstrated ability and eagerness to challenge status quo, act decisively and operate successfully in an empowered organization. </li><li>Existing knowledge of prostate or genitourinary cancers strongly preferred </li><li>Demonstrated ability to grow leaders and build/lead high performing cross-functional and cross-cultural teams strongly preferred </li></ul> <p>NON-STANDARD WORK SCHEDULE, TRAVEL OR ENVIRONMENT REQUIREMENTS</p> <ul> <li>Willingness to work flexible hours on a daily basis by managing stakeholders across multiple time zones during collaborations with colleagues based in the US, Europe, and Asia </li><li>Willingness to travel (~15-20% of time), including international travel </li></ul> <p>Other Job Details:</p> <p>Last Date to Apply for Job: July 1st, 2025</p> <p>Additional Location Information: New York, NY; Collegeville, PA; Cambridge, MA; Groton, CT; Bothell, WA, Lake Forest, IL; La Jolla, CA; San Francisco, CA</p> <p>Eligible for Relocation Package: No</p> <p>#LI-PFE</p> <p>The annual base salary for this position ranges from $219,800.00 to $366,400.00. In addition, this position is eligible for participation in Pfizer's Global Performance Plan with a bonus target of 25.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life's moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site - U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.</p> <p>Relocation assistance may be available based on business needs and/or eligibility.</p> <p>Sunshine Act</p> <p>Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care provider's name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.</p> <p>EEO & Employment Eligibility</p> <p>Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. This position requires permanent work authorization in the United States.</p> <p>Marketing and Market Research</p> <p>#LI-PFE</p>